Company / Working Capital
Prime Medicine, Inc. Working Capital History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$143.8M
FY2025
5-year range
$86.6M / $269.9M
FY2021-FY2025
Trend
-17.3%
vs FY2024
Sector context
#183 of 213
Health Care
What the data says
Prime Medicine, Inc.'s working capital of $144M is lower than 86% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 5 years, ranging from $87M in FY2023 to $270M in FY2022.
Based on SEC 10-K filings.
$144M in FY2025 with a 3-year CAGR of -18.9%.
Improved from $87M to $144M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -18.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 213This company $143.8M Sector average $934.6M
▼
-84.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -18.9%, indicating a declining trend.
- In FY2025, working capital decreased 17.3% year-over-year.
- Ranks #183 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $143.8M | -17.3% |
| FY2024 | $173.9M | +100.9% |
| FY2023 | $86.6M | -67.9% |
| FY2022 | $269.9M | +27.0% |
| FY2021 | $212.6M | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026